Inhibrx Announces $200M Private Placement Financing; In The PIPE, Co Is Selling An Aggregate Of 3,621,314 Shares Of Its Common Stock At A Price Of $19.35 Per Share
Portfolio Pulse from Happy Mohamed
Inhibrx, Inc. (NASDAQ:INBX) has announced a private placement financing deal that is expected to generate approximately $200 million in gross proceeds. The company is selling 3,621,314 shares of its common stock at $19.35 per share. The deal also includes pre-funded warrants to purchase up to 6,714,636 shares of common stock at a purchase price of $19.3499 per pre-funded warrant. The deal is expected to close by August 31, 2023.
August 29, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inhibrx's private placement financing deal is expected to generate significant capital, which could be used to fund the company's ongoing operations and development projects. This could potentially boost investor confidence in the company's financial stability.
The private placement financing deal is a significant development for Inhibrx as it provides the company with a substantial amount of capital. This could potentially boost investor confidence in the company's financial stability and its ability to fund its ongoing operations and development projects. As such, this news could have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100